ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX)
CUSIP: 45256X103
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 1,124,549,707
- Total 13F shares
- 149,650,186
- Share change
- +25,585,561
- Total reported value
- $368,148,509
- Put/Call ratio
- 129%
- Price per share
- $2.46
- Number of holders
- 258
- Value change
- +$61,432,781
- Number of buys
- 136
- Number of sells
- 80
Quarterly Holders Quick Answers
What is CUSIP 45256X103?
CUSIP 45256X103 identifies IBRX - ImmunityBio, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45256X103:
Top shareholders of IBRX - ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
1.9%
|
21,817,307
|
$57,597,690 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
1.6%
|
17,767,213
|
$46,905,442 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.78%
|
8,756,183
|
$23,116,323 | — | 30 Jun 2025 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
0.69%
|
7,764,000
|
$20,496,960 | — | 30 Jun 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.69%
|
7,718,265
|
$20,376,220 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.68%
|
7,615,566
|
$20,105,094 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.51%
|
5,777,269
|
$15,253,572 | — | 30 Jun 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.31%
|
3,445,871
|
$9,097,099 | — | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.29%
|
3,243,706
|
$8,563,384 | — | 30 Jun 2025 | |
| AlphaCore Capital LLC |
13F
|
Company |
0.26%
|
2,974,878
|
$7,853,678 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.26%
|
2,972,269
|
$7,846,791 | — | 30 Jun 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.22%
|
2,486,878
|
$6,565,358 | — | 30 Jun 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.21%
|
2,333,333
|
$6,159,999 | — | 30 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.16%
|
1,851,908
|
$4,889,037 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.16%
|
1,844,361
|
$4,869,113 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.16%
|
1,775,566
|
$4,687,494 | — | 30 Jun 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.11%
|
1,225,047
|
$3,233,000 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.11%
|
1,190,647
|
$3,143,308 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.1%
|
1,071,736
|
$2,829,383 | — | 30 Jun 2025 | |
| Clearwater Capital Advisors, LLC |
13F
|
Company |
0.08%
|
846,419
|
$2,234,547 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.07%
|
839,894
|
$2,217,322 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.07%
|
831,206
|
$2,194,384 | — | 30 Jun 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.07%
|
802,563
|
$2,118,766 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.07%
|
786,225
|
$2,075,634 | — | 30 Jun 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.07%
|
781,800
|
$2,063,952 | — | 30 Jun 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.07%
|
775,301
|
$2,046,795 | — | 30 Jun 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.07%
|
734,720
|
$1,939,660 | — | 30 Jun 2025 | |
| ALLEN HOLDING INC /NY |
13F
|
Company |
0.06%
|
687,571
|
$1,815,187 | — | 30 Jun 2025 | |
| SHEETS SMITH WEALTH MANAGEMENT |
13F
|
Company |
0.06%
|
633,475
|
$1,672,374 | — | 30 Jun 2025 | |
| Accurate Wealth Management, LLC |
13F
|
Company |
0.05%
|
560,000
|
$1,607,200 | — | 30 Jun 2025 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.05%
|
548,506
|
$1,448,055 | — | 30 Jun 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.04%
|
431,100
|
$1,138,104 | — | 30 Jun 2025 | |
| Swiss National Bank |
13F
|
Company |
0.04%
|
421,500
|
$1,112,760 | — | 30 Jun 2025 | |
| John C. Thomas |
3/4/5
|
Former Director |
—
class O/S missing
|
216,363
|
$1,086,143 | — | 31 Dec 2021 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.03%
|
351,875
|
$928,950 | — | 30 Jun 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.03%
|
334,557
|
$883,217 | — | 30 Jun 2025 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.03%
|
317,239
|
$837,511 | — | 30 Jun 2025 | |
| Sculptor Capital LP |
13F
|
Company |
0.03%
|
308,600
|
$814,704 | — | 30 Jun 2025 | |
| LPL Financial LLC |
13F
|
Company |
0.03%
|
306,503
|
$809,168 | — | 30 Jun 2025 | |
| Skandinaviska Enskilda Banken AB (publ) |
13F
|
Company |
0.03%
|
295,950
|
$778,349 | — | 30 Jun 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
273,113
|
$721,017 | — | 30 Jun 2025 | |
| Plancorp, LLC |
13F
|
Company |
0.02%
|
271,458
|
$716,649 | — | 30 Jun 2025 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.02%
|
252,468
|
$666,516 | — | 30 Jun 2025 | |
| Clearstead Advisors, LLC |
13F
|
Company |
0.02%
|
247,495
|
$653,387 | — | 30 Jun 2025 | |
| Verition Fund Management LLC |
13F
|
Company |
0.02%
|
245,801
|
$648,915 | — | 30 Jun 2025 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
0.02%
|
239,814
|
$633,109 | — | 30 Jun 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.02%
|
237,147
|
$626,068 | — | 30 Jun 2025 | |
| Corient Private Wealth LLC |
13F
|
Company |
0.02%
|
205,595
|
$542,771 | — | 30 Jun 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.02%
|
205,478
|
$542,464 | — | 30 Jun 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.02%
|
201,759
|
$532,642 | — | 30 Jun 2025 |
Institutional Holders of ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX) as of Q3 2025
As of 30 Sep 2025,
ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX) was held by
258 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
149,650,186 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., JANE STREET GROUP, LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, HEIGHTS CAPITAL MANAGEMENT, INC, HEIGHTS CAPITAL MANAGEMENT, INC, Woodline Partners LP, MORGAN STANLEY, and AlphaCore Capital LLC.
This page lists
258
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
236
Q3 2025 holders
258
Holder diff
22
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.